Rhythm Pharmaceuticals
Rhythm is a global biopharmaceutical company focused on rare neuroendocrine diseases. The General Manager for the GSA region leads strategy, operations, and business development efforts across Germany, Switzerland, and Austria, driving growth and ensuring local market success.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
71% above the average for this role
Commercial Lead - Germany, Austria & Switzerland
BridgeBio Pharma
Senior Director, Medical Affairs, Europe Central Region
BridgeBio Pharma
KAM Rare Diseases (Madrid)
Ipsen
Sales Executive (Switzerland, Austria, Southern Germany)
Pix4D
Brand Manager Switzerland And Austria Switzerland
alnylam
EHS Lead Germany, Austria, Switzerland
Carrier Enterprise